11 companies we recorded at EHA2026
These are the companies Bounce Watch has picked up as having been at EHA2026 in Stockholm, gathered from what they announced publicly. Each is listed with what it does and the date we recorded it, and the list stays up after the event closes. It is not the official exhibitor list — an event this size had many more companies than we saw, so read it as who we caught, not a roster.
Our record
There were almost certainly more — this is what we detected from public announcements.
- Speaking
- 6
- Attending
- 4
- Exhibiting
- 2
Get the list as a file
Excel with each company's role at the event, size, funding, public contacts and latest signals. Every company we have not checked in the last 30 days is re-scanned after you buy, so the file is current.
Get 3 rows free · EHA2026 companies
The list's first rows in Excel, with every column the full file has and how full each one is. One e-mail, then at most two short notes.
Who we saw at EHA2026
Novartis
Switzerland · 1996
Reimagining medicine by transforming cancer
Recorded 8 Jun 2026
Regulatory Approval · 7 Nov 2026
GSK
United Kingdom · 1715
Science-led global healthcare co with a special purpose: to help people to do more, feel better, live longer
Recorded 12 Jun 2026
Regulatory Approval · 10 Sep 2026
Eli Lilly and Company
United States · 1876
Discovery, development, manufacture, and sale of products in pharmaceutical products business segment
Recorded 14 Jun 2026
Key Exit Announced · 27 Oct 2026
Cellectis
France · 1999
Cellectis is developing genetic medicines for diseases that today demand a lifetime of treatment.
Recorded 15 Jun 2026
Regulatory Approval · 9 Jun 2026
Kite Pharma
United States · 2009
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Recorded 26 May 2026
New Product Launched · 26 May 2026
Caribou Biosciences
United States · 2012
Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases
Recorded 9 Jun 2026
Fundraising Intent · 18 May 2026
BlossomHill Therapeutics, Inc.
United States · 2020
Addressing urgent unmet medical needs through deeper science, true originality, and rich experience...
Recorded 12 May 2026
IPO Announced · 18 Sep 2026
Cullinan Therapeutics
United States · 2016
Science That Moves
Recorded 11 Jun 2026
Regulatory Approval · 19 May 2026
Mission Bio
United States · 2014
The Tapestri® Platform; the only technology that provides single-cell targeted DNA sequencing at single-base resolution.
Recorded 8 Jun 2026
New Feature Launched · 10 Jun 2026
Cogent Biosciences
United States · 2014
Precision therapeutics for genetically defined diseases. Real solutions for real challenges.
Recorded 14 May 2026
Regulatory Approval · 28 May 2026
Cellarity
United States · 2017
Rewriting the rules of drug creation
Recorded 3 Jun 2026
No company matches that.
What changed at these 11 companies recently?
We recorded 32 changes here in the last 180 days, including 11 milestones, 6 product launches, 5 awards, 3 traction updates and 2 leadership changes. Each entry below carries the date we observed it, from public sources.
-
Novartis
— Regulatory Approval
-
Eli Lilly and Company
— Key Exit Announced
-
BlossomHill Therapeutics, Inc.
— IPO Announced
-
GSK
— Regulatory Approval
-
Mission Bio
— New Feature Launched
-
Cellectis
— Regulatory Approval
-
Cogent Biosciences
— Regulatory Approval
-
Kite Pharma
— New Product Launched
Other events we have a record for — see all
From the desk
Were your competitors here? We noticed.
Our desk watches your competitive set every day and briefs you on what moved and what it signals.
